Patient-Centered Care in PD-1 Resistant Head and Neck Cancer
PD-1 resistance is not only a biological challenge—it is a deeply personal experience for patients navigating head and neck cancer. When an immunotherapy that once offered hope becomes less effective, patients may feel fear, frustration, or emotional exhaustion. Patient-centered care is essential in addressing both the medical and emotional dimensions of resistance.
Head and neck cancers often affect speech, swallowing, appearance, and social interaction, intensifying emotional stress. When resistance develops, patients may worry about limited options or declining quality of life. Clear, compassionate communication from healthcare providers helps patients understand that resistance is a known biological process, not a personal failure.
Patient-centered care emphasizes shared decision-making. Clinicians involve patients in treatment planning, discussing goals, expectations, and preferences. This collaborative approach empowers patients, helping them feel more in control during uncertain phases of care.
Supportive services play a vital role. Psychological counseling, nutritional guidance, speech therapy, and pain management help address the physical and emotional burdens of resistant disease. These services improve daily functioning and overall well-being, regardless of treatment outcomes.
By focusing on the whole person rather than the disease alone, patient-centered care ensures that dignity, comfort, and emotional resilience remain priorities throughout the cancer journey.